Anfield Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,433
| Closed | -$30.1K | – | 79 |
|
|
2022
Q4 | $30.1K | Buy |
2,433
+634
| +35% | +$7.86K | 0.01% | 77 |
|
|
2022
Q3 | $19K | Buy |
1,799
+58
| +3% | +$613 | 0.01% | 84 |
|
|
2022
Q2 | $20K | Buy |
1,741
+232
| +15% | +$2.67K | 0.01% | 89 |
|
|
2022
Q1 | $19K | Buy |
1,509
+825
| +121% | +$10.4K | 0.01% | 90 |
|
|
2021
Q4 | $8K | Buy |
684
+633
| +1,241% | +$7.4K | ﹤0.01% | 97 |
|
|
2021
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 116 |
|